MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

121 hedge funds and large institutions have $407M invested in Merrimack Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 15 closing their positions.

Holders
121
Holders Change
+19
Holders Change %
+18.63%
% of All Funds
3.48%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
31
Reduced
37
Closed
15
Calls
$7.79M
Puts
$5.19M
Net Calls
+$2.6M
Net Calls Change
-$2.21M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$15M
2
Deutsche Bank
2
Deutsche Bank
Germany
$17.8M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$4.15M
4
BFA
4
BlackRock Fund Advisors
California
$30.6M
5
Goldman Sachs
5
Goldman Sachs
New York
$4.8M

Top Sellers

1
State Street
1
State Street
Massachusetts
$24.8M
2
Jennison Associates
2
Jennison Associates
New York
$35.3M
3
DCM
3
DAFNA Capital Management
California
$0
4
CCA
4
Catalyst Capital Advisors
New York
$217K
5
Morgan Stanley
5
Morgan Stanley
New York
$3.67M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$113M 15,510,772 +23,004 +0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$39.3M 5,396,583 +125,957 +2%
Jennison Associates
3
Jennison Associates
New York
$35.3M 4,837,582 -1,001,678 -17%
BFA
4
BlackRock Fund Advisors
California
$30.6M 4,203,723 +544,741 +15%
State Street
5
State Street
Massachusetts
$24.8M 3,399,276 -1,242,346 -27%
Deutsche Bank
6
Deutsche Bank
Germany
$17.8M 2,436,028 +1,662,406 +215%
Millennium Management
7
Millennium Management
New York
$15M 2,055,592 +1,747,706 +568%
BIT
8
BlackRock Institutional Trust
California
$8.82M 1,209,383 -9,772 -0.8%
Northern Trust
9
Northern Trust
Illinois
$8.27M 1,133,939 -125,612 -10%
PI
10
Putnam Investments
Massachusetts
$6.33M 867,651 -152,881 -15%
UBS AM
11
UBS AM
Illinois
$5.87M 804,997 – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$5.82M 798,084 -253,558 -24%
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$5.58M 764,798 +445,732 +140%
CNB
14
City National Bank
California
$5.34M 732,225 +211,265 +41%
Goldman Sachs
15
Goldman Sachs
New York
$4.8M 658,179 +459,851 +232%
FCM
16
Farallon Capital Management
California
$4.45M 610,000 +292,684 +92%
Renaissance Technologies
17
Renaissance Technologies
New York
$4.15M 569,413 +569,413 New
TCM
18
Tekla Capital Management
Massachusetts
$4.14M 567,787 -189,263 -25%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$3.78M 518,585 +3,500 +0.7%
Morgan Stanley
20
Morgan Stanley
New York
$3.67M 503,088 -338,419 -40%
CS
21
Credit Suisse
Switzerland
$3.62M 496,366 +291,125 +142%
TCIM
22
TIAA CREF Investment Management
New York
$3.43M 471,123 +9,072 +2%
Fuller & Thaler Asset Management
23
Fuller & Thaler Asset Management
California
$3.33M 456,700 -68,100 -13%
William Blair & Company
24
William Blair & Company
Illinois
$3.08M 422,300 +42,725 +11%
Invesco
25
Invesco
Georgia
$2.86M 392,237 +392,237 New
1
2 3 4 5